2008
DOI: 10.1016/j.jmig.2008.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Early Results of Magnetic Resonance–guided Focused Ultrasound Surgery of Adenomyosis: Analysis of 20 Cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
60
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 75 publications
(65 citation statements)
references
References 34 publications
5
60
0
Order By: Relevance
“…Class A adverse effects have included abdominal pain, mild sciatic/ buttock pain, genital bleeding/increased discharge, and a prolonged next period. 37 Zhang et al 33 reported a slightly increased frequency of abdominal pain (64% vs 71%) and skin reaction (0.8/2.4%) in patients with diffuse adenomyosis compared with those with focal disease.…”
Section: Safety/complicationsmentioning
confidence: 97%
See 3 more Smart Citations
“…Class A adverse effects have included abdominal pain, mild sciatic/ buttock pain, genital bleeding/increased discharge, and a prolonged next period. 37 Zhang et al 33 reported a slightly increased frequency of abdominal pain (64% vs 71%) and skin reaction (0.8/2.4%) in patients with diffuse adenomyosis compared with those with focal disease.…”
Section: Safety/complicationsmentioning
confidence: 97%
“…Objective treatment success is demonstrated by a significant reduction in the uterine volume in several studies, with values from 12.7% to 54%. 36,37,41 The NPVR, where reported, ranges from 62.5% to 80.7% 33,35,36,39,41 (Table 1).…”
Section: Reduction Of Tissuementioning
confidence: 99%
See 2 more Smart Citations
“…Numerous therapeutic strategies such as hormone therapy, drug therapy, surgical intervention, uterine artery embolization and magnetic resonance-guided focused ultrasound (MRgFUS) ablation, are available to treat uterine fibroids and adenomyoma (2)(3)(4)(5)(6). The MRgFUS is proven to be a feasible, safe, efficacious treatment for uterine fibroids and adenomyoma (7)(8)(9)(10)(11)(12)(13)(14) by inducing coagulative necrosis, size reduction and functional loss of the lesion (7,15). The treatment outcome of MRgFUS ablation is normally assessed by contrast-enhanced T1-weighted image (cT1WI) with the use of gadolinium-based magnetic resonance contrast agent.…”
Section: Introductionmentioning
confidence: 99%